Risk of invasive meningococcal disease up with HIV/AIDS

October 29, 2013
Risk of invasive meningococcal disease up with HIV/AIDS
In New York City, people living with HIV/AIDS are at increased risk of contracting invasive meningococcal disease, according to a study published online Oct. 29 in the Annals of Internal Medicine.

(HealthDay)—In New York City, people living with HIV/AIDS (PLWHA) are at increased risk of contracting invasive meningococcal disease (IMD), according to a study published online Oct. 29 in the Annals of Internal Medicine.

Laura Miller, M.P.H., from the New York City Department of Health and Mental Hygiene, and colleagues estimated the risk of IMD and death in PLWHA using IMD surveillance data from 2000 to 2011. Data from 263 reported cases (aged 15 to 64) were matched to death and HIV registries to calculate IMD risk and case fatalities. Age-matched, case-control analyses were conducted using a subset of PLWHA who had a CD4+ count and viral load measurement near the time of their IMD infection.

The researchers identified 55 deaths among the 263 cases of IMD. The average annual incidence rate of IMD was 0.39 per 100,000, and the relative risk of IMD in PLWHA was 10.0 in the study period. Compared with age-matched controls, PLWHA with IMD were 5.3 times as likely to have CD4+ counts less than 200 x 109 cells/L.

"Cost effectiveness and vaccine efficacy studies are needed in order to evaluate the value of a national recommendation for routine meningococcal vaccination of PLWHA," the authors write.

Explore further: Immune system 'circuitry' that kills malaria in mosquitoes identified

More information: Full Text (subscription or payment may be required)

Related Stories

Meningococcal disease ID'd in men who have sex with men

June 18, 2013

(HealthDay)—Following reports of invasive meningococcal disease (IMD) among men who have sex with men (MSM), the New York City (NYC) Department of Health and Mental Hygiene (DOHMH) has recommended that MSM who have engaged ...

Recommended for you

HIV vaccine design should adapt as HIV virus mutates

May 16, 2016

Human immunodeficiency virus is known to be a highly variable virus that adapts to a person's immune response during the lifetime infection, and a new study published in Nature Medicine shows that viral adaptation in HIV ...

Study discovers new HIV vaccine target

May 12, 2016

A team led by scientists at the National Institutes of Health (NIH) has reported a research trifecta. They discovered a new vulnerable site on HIV for a vaccine to target, a broadly neutralizing antibody that binds to that ...

Researchers find alternative pathways to HIV antibodies

May 4, 2016

The immune system appears to hamper an investigational vaccine from inducing antibodies that protect against HIV infection, but there may be ways to overcome this impediment, according to research led by the Duke Human Vaccine ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.